SCHEMBL8725860

SCHEMBL8725860

CC(C)(C)C(=O)Cc1ccc(N(CCO)CCO)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.41
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CNR2 P34972 5/20 0.36
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
HIF1A Q16665 3/20 0.36
LMNA P02545 2/20 0.36
MAPT P10636 2/20 0.36
NFKB1 P19838 2/20 0.36
THPO P40225 2/20 0.36
PMP22 Q01453 2/20 0.36
TSHR P16473 2/20 0.36
GMNN O75496 1/20 0.36
CYP2D6 P10635 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
SLCO1B3 Q9NPD5 1/20 0.36
NR1H4 Q96RI1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18751674 0.80 CES1 (0.46) L3MBTL1ALDH1A1LMNATSHRPTGS1
SCHEMBL8238795 0.79 ALDH1A1 (0.48) NPSR1CNR2ALDH1A1SMN1; SMN2MAPT
SCHEMBL12102412 0.79 NR3C1 (0.50) ALDH1A1SMN1; SMN2HIF1ALMNAMAPT
SCHEMBL7472261 0.77 CYP4F2 (0.62) L3MBTL1ALDH1A1SMN1; SMN2LMNAMAPT
SCHEMBL16980999 0.77 NR1H4 (0.38) AOC3NPSR1L3MBTL1CNR2ALDH1A1
SCHEMBL16722805 0.74 ELANE (0.52) L3MBTL1ALDH1A1SMN1; SMN2LMNAALOX15
SCHEMBL6243535 0.73 MAPT (0.44) NPSR1L3MBTL1ALDH1A1SMN1; SMN2HIF1A
SCHEMBL11389533 0.72 HPGD (0.55) L3MBTL1ALDH1A1SMN1; SMN2LMNATDP1
SCHEMBL18116111 0.72 CA2 (0.56) ALDH1A1HIF1ALMNAMAPTNFKB1
SCHEMBL43229 0.72 LPL (0.40) NPSR1L3MBTL1CNR2ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0651740-B1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LTD (GB) 1998-10-21 EP disclosed
EP-0651740-A1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LIMITED (GB) 1995-05-10 EP disclosed
US-5405990-A For use in antibody directed enzyme prodrug therapy; cytotoxic parent nitrogen mustard; antitumor agents ZENECA LIMITED (GB) 1995-04-11 US disclosed
WO-1994002450-A1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LIMITED (GB) 1994-02-03 WO disclosed